Molecule is active against MYC-driven malignanciesAugust 13, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Study reveals potential targets for MYC-dependent cancersAugust 12, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Method could speed up cancer diagnosisAugust 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Gene plays crucial role in cancer development, team saysAugust 8, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Ofatumumab prompts fatal reaction in CLL patientAugust 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
CHMP recommends antifungal agentAugust 7, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyTransplantation
Protein-targeting drug could treat cancers, other diseasesAugust 6, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated Issues
Study reveals why HSCs falter with ageAugust 4, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersRelated IssuesTransplantation
Approach could improve treatment of lymphoma, other cancersAugust 1, 2014Lymphoma & Plasma Cell Disorders
Obinutuzumab approved for CLL in EuropeJuly 30, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
FDA expands approved use of ibrutinib in CLLJuly 29, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Healthy habits can cut risk of metabolic syndrome in childhood cancer survivorsJuly 29, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology NursingPediatrics
